As economies all around the world are suffering from the impact of Covid-19, businesses are experiencing losses, workers are without jobs, and many face the challenge of a complete upheaval of lifestyle. However, pharmaceutical companies taking centre stage in the Covid-19 fight and a new innovation in the infectious disease landscape as the race for treatment approval for a Covid-19 therapy takes off.
Pharmaceutical companies are on the line and their impact on the fight against the virus will not be easily forgotten. The concept of large profits coming from newly developed drugs will increased consider in a time of global pandemic as a result of public and competitive pressures.
Title : Drug Delivery to the Brain using Engineered Protein Capsules (EnPCs®)
Victoria Demina, NEUWAY Pharma GmbH, Germany
Title : NEWER ADVANCES OF ANTI –HIV THERAPY
Bhuvanesh baniya, Jai Narain Vyas University Jodhpur, India
Title : Insulin Resistance Associated Alzheimer Disease Condition in Rats is ameliorated via Epigenetic Regulation and Autophagy Modulation
Violina Kakoty, Birla Institute of Technology and Science-Pilani, India
Title : SELF MICROEMULSIFYING SYSTEMS BASED TOPICAL LIPSTICK OF ANTIFUNGAL AGENT
Bhupendra Gopalbhai Prajapati, Ganpat University, Shree S.K.Patel College of Pharmaceutical Education and Research, India
Title : Sol-gel, phase inversion precipitation and microfluidic systems for controlled delivery of pharmaceuticals and bioactive compounds in nutraceuticals and nano nutraceuticals
Sandile Phinda Songca, University of KwaZulu-Natal, South Africa
Title : The e?ects of Anethum graveolens (dill) supplementation on lipid profile and glycemic control: A systematic review and meta-analysis of randomized controlled trials
Seyed Mohammad Mousavi, Tehran University of Medical Sciences, Tehran, Iran., Iran (Islamic Republic of)